You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Novo Nordisk Articles
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Send a link to this page to your friends and colleagues.
On July 18, the San Francisco Chronicle reported that Pfizer announced in an earnings statement that the U.S. Food and Drug Administration would probably want more safety data about possible side effects that have surfaced during clinical trials. According to the Chronicle article, last month Pfizer and Inhale revealed that patients who took a combination of injected and inhaled insulin produced more antibodies to the drug than patients who only injected insulin.
Exubera, a dry insulin powder that is inhaled into the lungs using a special device, was originally expected to submitted to the FDA for marketing approval by the end of this year. Diabetes Health reported in its July issue that in clinical trials, one out of 1,000 patients that used Exubera developed lung damage.
Aradigm Corporation of Hayward, California, and Novo Nordisk are also developing an inhalable insulin called the AERx insulin delivery system.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.